Company intelligence / Profile preview

Independent Capital

Zurich, Zurich, Switzerland

Ownership: Private
Development stage: Other

Overview

Independent Capital Group (ICG) is a Swiss-based investment management firm that specializes in the healthcare and life sciences sectors. The company provides asset management and advisory services, focusing on identifying high-growth opportunities within biotechnology, medical technology, and pharmaceutical services. ICG manages specialized funds that invest in both public and private healthcare companies globally, leveraging deep industry expertise to support innovation in medicine. Their investment strategy emphasizes long-term value creation through a fundamental, research-driven approach to the life sciences market.

Industry: Investors

Beyond the preview

Go deeper on Independent Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Independent Capital.

Explore the full profile